Replication of yellow fever virus in the mouse central nervous system : Comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain

Journal of General Virology

Volumn 77, Issue 6, 1996, Pages 1277-1285

  Schlesinger, Jacob J ^a   Chapman, Susan ^a   Nestorowicz, Ann ^b   Rice, Charles M ^b   Ginocchio, Tara E ^c   Chambers, Thomas J ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VIRUS; ANIMALIA; FLAVIVIRUS;

COMPLEMENTARY DNA; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; FEMALE; MOUSE; NONHUMAN; OLFACTORY BULB; PARALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPINAL CORD; TISSUE DISTRIBUTION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

ANIMALS; BRAIN; CELL LINE; CERCOPITHECUS AETHIOPS; DEATH; FEMALE; GENOME, VIRAL; MICE; MICE, INBRED STRAINS; PARALYSIS; SPECIES SPECIFICITY; SPINAL CORD; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRUS REPLICATION; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 0029993135     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-6-1277     Document Type: Article

References (50)

1. AGOL, V. I., DZROZDOVB, S. G., GRACHEV. V. P., KOLESNIKOVA, M, S., KOZLOV. V. G., RALPH, N M., ROMANOVA, L. I., TOLSKAYA, E. A., TYUFANOV, A. V & VIKTOROVA, E. G. (1985). Recombinants between attenuated and virulent strains of poliovirus type 1 : derivation and characterization of recombinants with centrally located crossover points. Virology 143, 467-477.
2. BARRETT, A. D. T., MONATH. T. P., CROPP, C. P., ADKINS. J. D., LEDGER, T. N., GOULD, E. A., SCHLESINGER, J. J., KINNEY, R. M. & TRENT, D. W. (1990). Attenuation of wild-type yellow fever virus by passage in HeLa cells. Journal of General Virology 71, 2301-2306.
3. BLOK. J., McWILLIAM. S. M., BUTLER. H. C., GIBBS. A. J., WEILLER, G., HERRING, B. L., HEMSLEY, A. C., AASKOV, J. G., YOKSAN, S. & BHAMARAPRAVATI. N. (1992). Comparison of a dengue-2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses. Virology 187, 573-590.
4. BRANDRISS, M. W., SCHLESINGER, J. J., WALSH, E. E. & BRISELLI, M. (1986). Lethal 17D yellow fever encephalitis in mice I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. Journal of General Virology 67. 229-234.
5. BRAY, M. & LAI, C.-J. (1991). Construction of intertypic chimeric dengue viruses by substitution of structural proteins. Proceedings of the National Academy of Sciences, USA 88, 10342-10346.
6. BRAY, M., ZHAO, B. T., MARKOFF, L., ECKELS, K. H., CHANOCK, R. M. & LAI, C.-J. (1989). Mice immunized with recombinant vaccinia virus expressing dengue virus 4 structural proteins with or without NS1 are protected against fatal dengue virus encephalitis. Journal of Virology 63, 2853-2856.
7. CANE, P. A. & GOULD, E. A. (1989). Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus. Journal of General Virologv 70, 557-564.
8. CARP, R. I., DAVIDSON, A.I. & MERZ, P.A. (1971). A method for obtaining cerebrospinal fluid from mice Research in Veterinary Science 12, 499.
9. CECILIA, D. & GOULD, E A. (1991). Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181, 70-77
10. CHAMBERS, T. J., McCOURT, D. W. & RICE, C. M (1989). Yellow fever virus proteins NS2A, NS2B, and NS4B. identification and partial Nterminal amino acid sequence analysis. Virology 169, 100-109
11. CHAMBERS, T. J., HAHN, C. S., GALLER, R. & RICE, C. M. (1990). Flavivirus genome organization, expression and replication. Annual Review of Microbiology 44, 649-688.
12. CONVERSE, J. L., KOVATCH, R. M., PIJLLIAM, J. D., NAGLE, S. C., JR & SNYDER. E. M. (1971). Virulence and pathogenesis of yellow fever virus serially passaged in cell culture. Applied Microbiology 21, 1053-1057
13. FINDLAY, G. M. & CLARK, L. P. (1935). Infection with neurotropic yellow fever virus following instillation into the nares and conjunctival sac. Journal of Pathology and Bacteriology 40, 55-64.
14. GOULD, E. A., BUCKLEY, A., BARRETT, A D. T. & CAMMACK, N. (1986). Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67, 591-595
15. GRITSUN, T S., HOLMES, E. C. & GOULD, E. A. (1995). Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Research 35, 307-321.
16. HAHN. C. S., DALRYMPLE, J. M., STRAUSS, J. H. & RICE, C. M. (1987). Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine derived from it. Proceedings of the National Academy of Sciences, USA 84, 2019-2023
17. HARDY, F. M. (1963). The growth of Asibi strain yellow fever virus in tissue cultures. II. Modification of virus and cells. Journal of Infectious Diseases 113, 9-14
18. HEARN, H. J , JR. SOPER, W. T. & MILLER. W. S. (1965). Loss in virulence of yellow fever virus serially passed in HeLa cells. Proceedings of the Society for Experimental Biology and Medicine 119, 319-322.
19. HEARN, H. J., JR, CHAPPELL, W. A., DEMCHAK, P. & DOMINIK, J. W. (1966). Attenuation of aerosolized yellow fever virus after passage in cell culture. Bacteriological Reviews 30, 615-625
20. HASEGAWA, H., YOSHIDA. M., SHIOSAKA, T., FUJITA., S. & KOBAYASHI, Y. (1992) Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191, 158-65.
21. HIRSCH. M. S. & MURPHY, F. A. (1967). Effects of anti-thymocyte serum on 17-D yellow fever infection in adult mice. Nature 216, 179-180.
22. HOLZMANN, H., HEINZ, F. X., MANDL, C. M., GUIRAKHOO, F. & KUNZ, C. (1990). A single amino acid substitution in the envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. Journal of Virology 64, 5156-5159.
23. JENNINGS, A. D . WHITBY, J. E., MINOR, P. D. & BARRETT, A. D. T (1993). Nucleotide and deduced amino acid sequence of the envelope protein of the wild-type French viscerotropic strain of yellow fever virus and the French neurotropic vaccine strain derived from it. Virology 192, 692-695.
24. JENNINGS, A. D., GIBSON, C. A., MILLER, B. R., MATHEWS. J. H., MlTCHELL, C. J., ROEHRIG, J. T., WOOD, D. J., TAFFS, F., SlL, B. K., WHITBY, S. N., WHITBY, J. E., MONATH, T. P., MINOR, P. D., SANDERS, P. G. & BARRETT, A. D. T. (1994). Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated encephalitis Journal of Infectious Diseases 169, 512-518.
25. JIANG, W. R., LOWE, A , HIGGS, S., REID, H. & GOULD, E. A (1993). Single ammo acid codon changes detected in louping ill virus antibody-resistant mutants with reduced virulence. Journal of General Virology 74, 931-935.
26. KAWANO, H., ROSTAPSHOV, V., ROSEN, L. & LAI, C.-J. (1993). Genetic determinants of dengue type 4 virus neurovirulence for mice. Journal of Virology 67, 6567-6575.
27. KONISHI, E., PlNCUS, S., FONSECA, B. A. L., SHOPE, R. E., PAOLETTI, E. & MASON, P. W. (1991). Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology 185, 401-410.
28. LIN, C., AMBERG, S. M., CHAMBERS, T. J. & RICE, C. M. (1993). Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. Journal of Virology 67, 2327-2335.
29. LOBIGS. M., USHA, R., NESTOROWICZ, A., MARSHALL, I. D., WEIR, R. C. & DALGARNO, L. (1990). Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176. 587-595.
30. McMINN, P. C., MARSHALL, I. D. & DALGARNO, L. (1995a). Neurovirulence and neuroinvasiveness of Murray Valley encephalitis virus mutants selected by passage in a monkey kidney cell line. Journal of General Virology 76, 865-872.
31. McMINN, P. C., LEE, E., HARTLEY, S., ROEHRIG, J. T., DALGARNO, L. & WEIR, R. C. (1995 b). Murray Valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology 211, 10-20.
32. MEERS, P.D. (1959). Adaptation of the 17D yellow fever virus to mouse brain by serial passage. Transactions of the Royal Society of Tropical Medicine and Hygiene 53, 445-457.
33. MONATH, T. P., CROPP, C. B. & HARRISON, A K. (1983). Mode of entry of a neurotropic arbovirus into the central nervous system: Reinvestigation of an old controversy. Labaratorv Investigation 48, 399-41O.
34. NlTAYAPHAN. S., GRANT, J. A., CHANG, G.-J. J. & TRENT, D. W. (1990). Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-2. Virology 177, 541-552.
35. OGATA, A , NAGASHIMA, K, HALL, W. H., ICHIKAWA, M., KIMURAKURODA, J. & YASUI, K. (1991). Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. Journal of Virology 65, 880-886.
36. OMATA, T., KOHARA, M., KUGE, S., KOMATSU, T., ABE, S., SEMLER, B. L., KAMEDA. A., ITOH. H., ARITA, M., WIMMER, E. & NOMOTO. A. (1986). Genetic analysis of the attenuation phenotype of poliovirus type 1. Journal of Virology 58, 348-358.
37. PLETNEV, A. G., BRAY, M. & LAI, C.-J. (1993) Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. Journal of Virology 67, 4956-4963.
38. REY, F. A., HEINZ, F. X., MANDL, C., KUNZ, C. & HARRISON, S. (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375, 291-298.
39. RICE, C. M., LENCHES, E. M., EDDY, S. R., SHIN, S. J., SHEETS, R. L. & STRAUSS, J. H. (1985) Nucieotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229, 726-733.
40. RICE, C. M., STRAUSS, E. G. & STRAUSS, J. H. (1986). Structure of the ftavivirus genome. In The Togaviridue and Flaviviridae, pp. 279-326. Edited by S Schlessinger and M. J. Schlessinger, New York: Plenum Press.
41. RICE, C. M., GRAKOUI, A., GALLER, R & CHAMBERS, T. J. (1989). Transcription of infectious yellow fever virus RNA from full-length cDNA templates produced by in vitro ligation New Biologist 1. 285-296.
42. SABIX, A B. (1952). Nature of inherited resistance to viruses affecting the nervous system. Proceedings of the National Academy of Sciences, USA 38, 540-546.
43. SCHLESINGER. R. W. (1980). Virus-host interactions in natural and experimental infections with alphaviruses and flaviviruses. In The Togaviruses, pp. 83-104. Edited by R. W. Schlesinger. New York & London: Academic Press
44. SCHLESINQER. J. J., BRANDRISS. M. W. & WALSH, E. E. (1985). Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the non-structural glycoprotein gp48 and by active immunization with gp48. Journal of Immunology 135, 2805-2809.
45. SCHLESINGER, J. J., BRANDRISS. M. W., CROPP, C. B & MONATH, T. P. (1986). Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. Journal of Virology 60, 1153-1155.
46. SCHLESINGER, J. J., BRANDRISS. M. W., PUTNAK, J. R. & WALSH, E. E. (1990). Cell surface expression of yellow fever virus nonstructural glycoprotein NS1 : consequences of interaction with antibody. Journal of General Virology 71, 593-599.
47. SUMIYOSHI, H. TIGNOR, G H. & SHOPE, R. E (1995). Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. Journal of Infectious Diseases 171, 1144-1151.
48. TARDY-PANIT, M., BLONDEL, B., MARTIN, A., TEKAIA, F., HORAUD, F. & DELPEYROUX. F. (1993). A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. Journal of Virology 67, 4630-4638.
49. THEILER, M. (1951). The virus. In Yellow Fever, pp. 46-136. Edited by G. K. Strode. New York: McGraw-Hill.
50. ZAR, J. H. (1974). Nonparametric tests. In Biostatistical Analysis, pp. 151-162. New Jersey: Prentice-Hall.